13-cis-retinoic acid,Isotretinoin

13-cis-retinoic acid,isotretinoin is a lipid of Prenol Lipids (PR) class. 13-cis-retinoic acid,isotretinoin is associated with abnormalities such as Dermatitis, Phototoxic. The involved functions are known as Regulation, Pigment, chromophore, Light absorption and Pupil constriction. 13-cis-retinoic acid,isotretinoin often locates in Neurosecretory Systems. The associated genes with 13-cis-retinoic acid,Isotretinoin are melanopsin.

Cross Reference

Introduction

To understand associated biological information of 13-cis-retinoic acid,Isotretinoin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 13-cis-retinoic acid,Isotretinoin?

13-cis-retinoic acid,Isotretinoin is suspected in Dermatitis, Phototoxic and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 13-cis-retinoic acid,Isotretinoin

MeSH term MeSH ID Detail
Lung Neoplasms D008175 171 associated lipids
Acne Vulgaris D000152 35 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with 13-cis-retinoic acid,Isotretinoin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 13-cis-retinoic acid,Isotretinoin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

What genes are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 13-cis-retinoic acid,Isotretinoin

Download all related citations
Per page 10 20 50 100 | Total 2952
Authors Title Published Journal PubMed Link
Kameoka S et al. A high-throughput screen for teratogens using human pluripotent stem cells. 2014 Toxicol. Sci. pmid:24154490
Hsu CW et al. Quantitative high-throughput profiling of environmental chemicals and drugs that modulate farnesoid X receptor. 2014 Sci Rep pmid:25257666
Bagatin E et al. Low-dose oral isotretinoin versus topical retinoic acid for photoaging: a randomized, comparative study. 2014 Int. J. Dermatol. pmid:24168514
Collins MK et al. Compliance with pregnancy prevention measures during isotretinoin therapy. 2014 J. Am. Acad. Dermatol. pmid:24157382
Cheung NK et al. Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma. 2014 Int. J. Cancer pmid:24644014
Hamoudi MC and Bochot A Oil-cyclodextrin based beads for oral delivery of poorly-soluble drugs. 2014 Curr Top Med Chem pmid:24354669
Tenner S Isotretinoin and inflammatory bowel disease: trial lawyer misuse of science and FDA warnings. 2014 Am. J. Gastroenterol. pmid:24698863
Dalal A et al. [Isotretinoin and exercise: can the two walk together?]. 2014 Harefuah pmid:24716429
Tan J et al. A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin. 2014 Br. J. Dermatol. pmid:24934963
Altman EM Isotretinoin and pregnancy prevention: do we need to take a long, hard look at ourselves? 2014 JAMA Dermatol pmid:24258339
Werner CA et al. Women's experiences with isotretinoin risk reduction counseling. 2014 JAMA Dermatol pmid:24258663
Sonawane P et al. Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma. 2014 Br. J. Pharmacol. pmid:25039756
Shimakami T et al. The acyclic retinoid Peretinoin inhibits hepatitis C virus replication and infectious virus release in vitro. 2014 Sci Rep pmid:24732793
Gusenleitner D et al. Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action. 2014 PLoS ONE pmid:25058030
Marrouche N et al. Pityriasis rubra pilaris: clinicopathological study of 32 cases from Lebanon. 2014 Int. J. Dermatol. pmid:24783259
Vora P et al. Revealed: The spy who regulates neuroblastoma stem cells. 2014 Oncotarget pmid:25483101
Matthay KK et al. Reply to N.-K.V. Cheung et al. 2014 J. Clin. Oncol. pmid:25403223
Zomerdijk IM et al. Isotretinoin exposure during pregnancy: a population-based study in The Netherlands. 2014 BMJ Open pmid:25392022
Gerber PA et al. Severe hyperpigmentation and scarring following glycolic acid peel treatment in combination with low-dose isotretinoin. 2014 Eur. J. Med. Res. pmid:25376482
Moghimi J et al. Isotretinoin-associated Sweet's syndrome: a case report. 2014 Daru pmid:25324016
Torabi B and Shemirani F A new approach to highly sensitive determination of retinoic acid isomers by preconcentration with CdSe quantum dots. 2014 Talanta pmid:24468339
Miller IM et al. Infantile acne treated with oral isotretinoin. 2013 Sep-Oct Pediatr Dermatol pmid:23278140
On SC and Zeichner J Isotretinoin updates. 2013 Sep-Oct Dermatol Ther pmid:24099068
Tan J and Knezevic S Improving bioavailability with a novel isotretinoin formulation (isotretinoin-Lidose). 2013 Sep-Oct Skin Therapy Lett. pmid:24305729
Kiratli H and Dikmetaş Ö Bilateral lacrimal gland enlargement associated with isotretinoin treatment. 2013 Nov-Dec Ophthal Plast Reconstr Surg pmid:23511995
Geller AS and Alagia RF Sacroiliitis after use of oral isotretinoin--association with acne fulminans or adverse effect? 2013 Nov-Dec An Bras Dermatol pmid:24346917
Sarici D et al. Asymmetric crying face in a newborn with isotretinoin embryopathy. 2013 Nov-Dec Pediatr Dermatol pmid:22612313
Scheinfeld N ABSORICA (isotretinoin): a new form. 2013 Mar-Apr Skinmed pmid:23745231
Topal IO et al. Generalized lichen nitidus: successful treatment with systemic isotretinoin. 2013 Jul-Aug Indian J Dermatol Venereol Leprol pmid:23760340
Santos-Pérez MI et al. [Suspicion of diabetes mellitus isotretinoin-induced]. 2013 Jul-Aug Farm Hosp pmid:24010698
Preneau S et al. Predictive markers of response to isotretinoin in female acne. 2013 Jul-Aug Eur J Dermatol pmid:23797561
Digiovanna JJ et al. Systemic retinoids in the management of ichthyoses and related skin types. 2013 Jan-Feb Dermatol Ther pmid:23384018
Raza K et al. Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne. 2013 Colloids Surf B Biointerfaces pmid:23357735
Raza K et al. Nano-lipoidal carriers of isotretinoin with anti-aging potential: formulation, characterization and biochemical evaluation. 2013 J Drug Target pmid:23336181
Bettoli V et al. Retinoids in the chemoprevention of non-melanoma skin cancers: why, when and how. 2013 J Dermatolog Treat pmid:23148804
Huoh KC and Chang KW Lip abscess associated with isotretinoin treatment of acne vulgaris. 2013 JAMA Dermatol pmid:23760516
Boyraz N and Mustak PK Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris. 2013 Int. J. Dermatol. pmid:23675954
Crijns I et al. Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study. 2013 Expert Opin Drug Saf pmid:23163396
Pinheiro SP et al. Concomitant use of isotretinoin and contraceptives before and after iPledge in the United States. 2013 Pharmacoepidemiol Drug Saf pmid:23913625
In Brief: Absorica for acne. 2013 Med Lett Drugs Ther pmid:24892143
Webster GF et al. Comparative pharmacokinetic profiles of a novel isotretinoin formulation (isotretinoin-Lidose) and the innovator isotretinoin formulation: a randomized, 4-treatment, crossover study. 2013 J. Am. Acad. Dermatol. pmid:23953888
Morales-Cardona CA and Sánchez-Vanegas G Acne relapse rate and predictors of relapse following treatment with oral isotretinoin. 2013 Actas Dermosifiliogr pmid:22795452
Soriano EA et al. Cardiac remodeling induced by 13-cis retinoic acid treatment in acne patients. 2013 Int. J. Cardiol. pmid:21663986
D'Erme AM et al. Association between isotretinoin and mood changes: myth or reality? An updated overview. 2013 Int. J. Dermatol. pmid:21913911
Popescu CM and Bigby M The weight of evidence on the association of isotretinoin use and the development of inflammatory bowel disease. 2013 JAMA Dermatol pmid:23426480
Nya-Ngatchou JJ et al. Intratesticular 13-cis retinoic acid is lower in men with abnormal semen analyses: a pilot study. 2013 Andrology pmid:23413144
Park HC et al. Treatment of multiple eccrine hidrocystomas with isotretinoin followed by carbon dioxide laser. 2013 J. Dermatol. pmid:23414089
Aktürk AŞ et al. Effects of isotretinoin on serum vitamin E levels in patients with acne. 2013 Int. J. Dermatol. pmid:23414163
Stuart SA et al. A translational rodent assay of affective biases in depression and antidepressant therapy. 2013 Neuropsychopharmacology pmid:23503126
Snyder R and Thekkumkara T Interplay between EGR1 and SP1 is critical for 13-cis retinoic acid-mediated transcriptional repression of angiotensin type 1A receptor. 2013 J. Mol. Endocrinol. pmid:23475749